Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir. - Test2 - elhamkhani - TriplyDB

Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.

Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.

http://www.wikidata.org/entity/Q34100187

about

A randomized clinical trial evaluating therapeutic drug monitoring (TDM) for protease inhibitor-based regimens in antiretroviral-experienced HIV-infected individuals: week 48 results of the A5146 study.Clinical pharmacokinetics of antiretroviral drugs in older persons.Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction.Short communication: Aging not gender is associated with high atazanavir plasma concentrations in Asian HIV-infected patients.A dedicated clinic for HIV-positive individuals over 50 years of age: a multidisciplinary experience.Pharmacological management of cardiovascular conditions and diabetes in older adults with HIV infection.Ageing with HIV: a multidisciplinary review.Antiretroviral Treatment Efficacy and Safety in Older HIV-Infected Adults.Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection.Impact of efavirenz pharmacokinetics and pharmacogenomics on neuropsychological performance in older HIV-infected patients.Precision medicine for HIV: where are we?Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective

P2860

Q35894312-6008ED85-CF62-4423-A327-914D1673CF37 Q36905884-A817B908-2761-4647-8CF1-7B8FA3F74B5F Q37247131-4C51B142-04CB-435A-BD2F-60BC0AA12385 Q37359252-91837299-F062-46D6-9877-9C92B0F9FDA2 Q38038817-30256FAE-2636-48B9-92FA-A3660AE99224 Q38172305-28391CA0-1015-4FF8-83DC-84E346D08467 Q38490362-A7335906-EF3F-4BB8-900D-2B52252BFBFB Q38673884-220FE5DA-7223-4850-A320-103F4CB1ACCD Q40360498-F6522A0B-C18B-42DE-9340-A746B1B6FE03 Q40531475-D8269419-E0C2-4F40-AAF3-58EF1203DE92 Q47569821-CA2B794D-9921-4182-A0BE-752EC699AF82 Q58073610-8F34DA22-33A5-4AD4-BE57-74BC360A41A1

P2860

Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.

http://www.wikidata.org/entity/Q34100187

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.

@ast

Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.

@en

Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.

@nl

type

label

Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.

@ast

Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.

@en

Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.

@nl

prefLabel

Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.

@ast

Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.

@en

Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.

@nl

P1433

Q34100187-46415569-B993-4BD5-8994-28FDDDCFB322

P1476

Q34100187-653FF6F1-9EA9-4881-92D5-AC522801A8EB

P2093

Q34100187-1F5D0D85-FF27-4755-B3E6-24043B64264C

Q34100187-26956B45-FD0B-42A6-ADF2-7881FDB0737D

Q34100187-49223F62-13B5-4E96-9C34-30BE9C4EBC4F

Q34100187-4FACC20B-EA79-4822-A145-220944749B64

Q34100187-6E5C7EC0-62D4-4D68-AEEB-B04E08BFEFD0

Q34100187-8B321960-F557-4E17-89FA-DCE7600F47E2

Q34100187-BAC3864E-019F-4190-8FCE-5A0772590888

Q34100187-C12E5D5A-1551-448F-8AFE-B8BE55BC151E

Q34100187-E5778D7F-1C71-4282-86B0-5A692D9F1AB4

Q34100187-E58AB2AF-4740-424E-AABA-60248A9F7394

P2860

Q34100187-01B546D1-7250-4890-9D7A-FAA59DDFEED9

Q34100187-01F2C7BF-9EF0-4F31-A753-D9708118E31F

Q34100187-14832969-C4DC-4C53-912A-25C6FAC46101

Q34100187-162D6800-7A78-4026-9107-8B89F61D737B

Q34100187-202BE63D-D48C-4F3D-9533-6276FC7C0DDC

Q34100187-2892E624-3F14-48C1-8345-7932A2F6BEC2

Q34100187-29AA4276-BB41-487F-AB8D-52DDE0B377FC

Q34100187-2F5B1CD2-2F3A-4C13-B217-0406910B231E

Q34100187-32E614DF-AFF8-458B-9C04-6A662856E3A9

Q34100187-3502450E-E173-4B0B-8B4B-D95FAA08620C

P304

Q34100187-63597634-D54F-4ABC-8773-DADCE0191C9A

P31

Q34100187-E47993CE-7614-40CB-8D92-7D9F465E6324

P356

Q34100187-E338D8FB-C5E8-442B-B537-370FCA71C0E4

P433

Q34100187-54A15460-30BB-4C72-9C33-3A9CFCAB6CDF

P478

Q34100187-07E9CCBB-0A4F-4C30-8178-BACC5D012237

P577

Q34100187-BF091BC6-76A7-48E6-9B7A-44651DDEBD48

P5875

Q34100187-60FEC667-A6A8-4C4C-A45C-2F499503D166

P698

Q34100187-275B012C-2242-415E-80E8-6E23C5053866

P932

Q34100187-ECBF5EA6-0D46-40A6-B954-8B9E514CCF73

P356

P1433

AIDS Research and Human Retroviruses

P1476

Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.

@en

P2093

AIDS Clinical Trials Protocol 5015 Team

http://www.w3.org/2001/XMLSchema#string

Alan Landay

http://www.w3.org/2001/XMLSchema#string

Charles Flexner

http://www.w3.org/2001/XMLSchema#string

John Spritzler

http://www.w3.org/2001/XMLSchema#string

Keith W Crawford

http://www.w3.org/2001/XMLSchema#string

Michael M Lederman

http://www.w3.org/2001/XMLSchema#string

Richard Pollard

http://www.w3.org/2001/XMLSchema#string

Robert C Kalayjian

http://www.w3.org/2001/XMLSchema#string

Teresa Parsons

http://www.w3.org/2001/XMLSchema#string

Vicki Stocker

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of alpha1-acid glycoprotein on the intracellular accumulation of the HIV protease inhibitors saquinavir, ritonavir and indinavir in vitro

Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more.

Effect of early versus deferred antiretroviral therapy for HIV on survival.

Cytochrome P450 3A: ontogeny and drug disposition.

Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy.

Liver function and phase I drug metabolism in the elderly: a paradox.

Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies.

Sex-related differences in the clearance of cytochrome P450 3A4 substrates may be caused by P-glycoprotein.

P304

635-643

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/AID.2009.0154

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44685438

http://www.w3.org/2001/XMLSchema#string

P698

20560793

http://www.w3.org/2001/XMLSchema#string

P932

2932550

http://www.w3.org/2001/XMLSchema#string